Talking Biotech with Dr. Kevin Folta
Science:Life Sciences
The gene editing explosion has accelerated discovery, food and therapies by defining a new toolbox of useful ways to manipulate DNA. The “Cas” series of enzymes are the core machinery of the editing process, and now scientists are identifying new molecules that inhibit these molecular scissors. Dr. Joseph Bondy-Denomy rides at the front edge of this discovery, and his program is characterizing the naturally-occurring factors in a bacteria/virus arms race that play a role in modulating Cas activity.
Follow Dr. Bondy-Denomy on Twitter: @joebondydenomy
The Bondy-Denomy Lab website: Here.
Conclusion music is Sleepwalk by Santo and Johnny, 1959.
# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/
# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq
The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
More Episodes
2021-12-25
2021-12-18
2021-12-11
2021-12-04
2021-11-27
2021-11-20
2021-11-13
2021-11-06
2021-10-30
2021-10-16
2021-10-09
2021-10-02
2021-09-25
2021-09-11
Get this podcast on your
phone, FREE
